Clinical Trial Search

Primary: Change From Baseline in Treatment Response as Measured by the Total Score on the O'Leary-Sant Questionnaire — -6.7; -5.8 scores on a scale

Primary: Presence of a CAC-Adjudicated Catheter-Related Bloodstream Infection (CRBSI) in Subjects Receiving Hemodialysis for the Treatment of End Stage Renal Disease (ESRD)…

Primary: Supine Slow Vital Capacity (SVC) — -6.731; -6.988 percentage — p=0.8253

Primary: Characterize Contribution of Histamine in Children With Asthma — 11253.24; 6464.20; 3539.67 flux units on a continuous scale

Primary: Percentage of Participants With Vaccine Seroresponse Against Meningococcal Serogroups A, C, Y, and W Following Vaccination With MenACYW Conjugate Vaccine in Study MET59…

Primary: Overall Survival (OS) of Patients — 7.8; 7.5 months

Primary: Percent of Patients With a Clinical Outcome of Clinical Cure (Resolution of All Clinical Signs and Symptoms of Infection) — 69; 41; 36 percentage of subjects

Primary: Change in Verbal Memory Scores From Baseline to 4 Hours Post-Treatment — 53.90; 40.49; 53.03; 38.49 score on a scale

Primary: Percentage of Patients With at Least 5% Weight Loss. — 80; 62 Participants — p=0.0352

Primary: Participants With "Controlled Disease" According to the Investigator's Global Assessment(IGA) of Disease Severity of the Face at Week 8 (Visit 6) in the Double-blind…

Primary: Mean Percent Change From Baseline in Fasting Triglyceride (TG) — -59.8; -49.2; -64.9; -45.5 percent change

Primary: PASI 75 Response After 12 Weeks of Treatment — 39; 34; 4 Participants — p=<0.0001

Primary: Granulomas — 12; 352; 0; 0 Participants

Primary: Clinical Cure (Resolution of All Clinical Signs and Symptoms of Infection) — 115; 64; 48 Participants

Primary: Overall Survival (OS) — 12.88; 8.97 months — p=0.00142